Comparative Immunogenicity of Plasma and Recombinant Hepatitis B Virus Vaccines in Homosexual Men

Nancy Odaka, Lois Eldred, Sylvia Cohn, Alvaro Munoz, Howard A. Fields, Robin Fox, Rachel Solomon, Richard Kaslow, B. Frank Polk

Research output: Contribution to journalArticle

Abstract

A randomized, double-blind clinical trial of plasma-derived and DNA recombinant hepatitis B virus vaccines was conducted in 186 homosexual men. Nine months after the immunization series (three doses) began, the seroconversion rate in the plasma vaccine group was 88% (68/77); this was significantly higher than the 74% (60/81) response rate of the recombinant vaccine group. Men positive for antibody to the human immunodeficiency virus (HIV) had a considerably higher nonresponse rate to either vaccine than expected in non—HIV-infected homosexual men. The odds ratios of nonresponse to hepatitis B virus vaccine for HIV-seropositive vs HIV-seronegative subjects were 12.0 (95% confidence interval, 1.7to 89.3) and 13.6 (95% confidence interval, 2.3 to 148.3) for the plasma and DNA recombinant vaccines, respectively.

Original languageEnglish (US)
Pages (from-to)3635-3637
Number of pages3
JournalJournal of the American Medical Association
Volume260
Issue number24
DOIs
StatePublished - Dec 23 1988

Fingerprint

Hepatitis B Vaccines
Synthetic Vaccines
Hepatitis B virus
HIV
Vaccines
Confidence Intervals
DNA Vaccines
Immunization
Odds Ratio
Clinical Trials
Antibodies
DNA
Sexual Minorities

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Comparative Immunogenicity of Plasma and Recombinant Hepatitis B Virus Vaccines in Homosexual Men. / Odaka, Nancy; Eldred, Lois; Cohn, Sylvia; Munoz, Alvaro; Fields, Howard A.; Fox, Robin; Solomon, Rachel; Kaslow, Richard; Polk, B. Frank.

In: Journal of the American Medical Association, Vol. 260, No. 24, 23.12.1988, p. 3635-3637.

Research output: Contribution to journalArticle

Odaka, Nancy ; Eldred, Lois ; Cohn, Sylvia ; Munoz, Alvaro ; Fields, Howard A. ; Fox, Robin ; Solomon, Rachel ; Kaslow, Richard ; Polk, B. Frank. / Comparative Immunogenicity of Plasma and Recombinant Hepatitis B Virus Vaccines in Homosexual Men. In: Journal of the American Medical Association. 1988 ; Vol. 260, No. 24. pp. 3635-3637.
@article{638aff6025d14902902e917358c2b059,
title = "Comparative Immunogenicity of Plasma and Recombinant Hepatitis B Virus Vaccines in Homosexual Men",
abstract = "A randomized, double-blind clinical trial of plasma-derived and DNA recombinant hepatitis B virus vaccines was conducted in 186 homosexual men. Nine months after the immunization series (three doses) began, the seroconversion rate in the plasma vaccine group was 88{\%} (68/77); this was significantly higher than the 74{\%} (60/81) response rate of the recombinant vaccine group. Men positive for antibody to the human immunodeficiency virus (HIV) had a considerably higher nonresponse rate to either vaccine than expected in non—HIV-infected homosexual men. The odds ratios of nonresponse to hepatitis B virus vaccine for HIV-seropositive vs HIV-seronegative subjects were 12.0 (95{\%} confidence interval, 1.7to 89.3) and 13.6 (95{\%} confidence interval, 2.3 to 148.3) for the plasma and DNA recombinant vaccines, respectively.",
author = "Nancy Odaka and Lois Eldred and Sylvia Cohn and Alvaro Munoz and Fields, {Howard A.} and Robin Fox and Rachel Solomon and Richard Kaslow and Polk, {B. Frank}",
year = "1988",
month = "12",
day = "23",
doi = "10.1001/jama.1988.03410240105040",
language = "English (US)",
volume = "260",
pages = "3635--3637",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "24",

}

TY - JOUR

T1 - Comparative Immunogenicity of Plasma and Recombinant Hepatitis B Virus Vaccines in Homosexual Men

AU - Odaka, Nancy

AU - Eldred, Lois

AU - Cohn, Sylvia

AU - Munoz, Alvaro

AU - Fields, Howard A.

AU - Fox, Robin

AU - Solomon, Rachel

AU - Kaslow, Richard

AU - Polk, B. Frank

PY - 1988/12/23

Y1 - 1988/12/23

N2 - A randomized, double-blind clinical trial of plasma-derived and DNA recombinant hepatitis B virus vaccines was conducted in 186 homosexual men. Nine months after the immunization series (three doses) began, the seroconversion rate in the plasma vaccine group was 88% (68/77); this was significantly higher than the 74% (60/81) response rate of the recombinant vaccine group. Men positive for antibody to the human immunodeficiency virus (HIV) had a considerably higher nonresponse rate to either vaccine than expected in non—HIV-infected homosexual men. The odds ratios of nonresponse to hepatitis B virus vaccine for HIV-seropositive vs HIV-seronegative subjects were 12.0 (95% confidence interval, 1.7to 89.3) and 13.6 (95% confidence interval, 2.3 to 148.3) for the plasma and DNA recombinant vaccines, respectively.

AB - A randomized, double-blind clinical trial of plasma-derived and DNA recombinant hepatitis B virus vaccines was conducted in 186 homosexual men. Nine months after the immunization series (three doses) began, the seroconversion rate in the plasma vaccine group was 88% (68/77); this was significantly higher than the 74% (60/81) response rate of the recombinant vaccine group. Men positive for antibody to the human immunodeficiency virus (HIV) had a considerably higher nonresponse rate to either vaccine than expected in non—HIV-infected homosexual men. The odds ratios of nonresponse to hepatitis B virus vaccine for HIV-seropositive vs HIV-seronegative subjects were 12.0 (95% confidence interval, 1.7to 89.3) and 13.6 (95% confidence interval, 2.3 to 148.3) for the plasma and DNA recombinant vaccines, respectively.

UR - http://www.scopus.com/inward/record.url?scp=0024210485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024210485&partnerID=8YFLogxK

U2 - 10.1001/jama.1988.03410240105040

DO - 10.1001/jama.1988.03410240105040

M3 - Article

C2 - 2973531

AN - SCOPUS:0024210485

VL - 260

SP - 3635

EP - 3637

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 24

ER -